The purpose of this open-label study is to assess liver iron concentration using MRI imaging in subjects with beta-thalassemia when administered with either SPD602 or deferasirox for the treatment of chronic transfusional iron overload. The study will start in October 2013 and it is expected to be completed in July 2015.

More information: clinicaltrials.gov, ITHANET Clinical Trials